Dose Finding Study of BI 836880 in Patients With Solid Tumors

NCT02674152 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim